# US pharma companies raise 2026 outlooks

> Live situation record from CLSTR: https://clstr.news/situations/us-pharma-companies-raise-2026-outlooks
> Updated: 2026-08-04T11:28:00.000Z. Sources: 23. Developments: 2.

In late July, Bristol Myers Squibb reported second‑quarter results that showed a 6 % year‑over‑year revenue increase and lifted its full‑year 2026 revenue guidance to $49‑$50 billion, with earnings expectations raised to $6.75‑$7.00 per share. The company highlighted strong growth in its anticoagulant Eliquis and solid performance from newer products such as Camzyos, Reblozyl, Breyanzi and the sub‑cutaneous version of Opdivo.

A week later, Pfizer announced an upward revision of its median 2026 sales outlook to $60.5‑$62.5 billion after better‑than‑expected demand for Eliquis and the heart‑disease drug Vyndaqel in the second quarter. While reporting modest revenue growth, Pfizer disclosed a $4.3 billion goodwill impairment and outlined an extension of its cost‑cutting program through 2029, targeting additional savings via automation, AI tools and staff reductions.

Both firms’ guidance upgrades reflect a broader trend among major U.S. pharmaceutical companies of boosting 2026 forecasts amid strong demand for anticoagulants and other high‑growth therapies.

## Timeline

### 2026-08-04: Pfizer lifts 2026 sales forecast to up to $62.5 billion

Pfizer raised its 2026 sales outlook to $60.5‑62.5 bn after a strong Q2, reporting $15 bn revenue, adjusted EPS $0.77 and extending its $7 bn cost‑cut plan.

3 sources. https://clstr.news/cluster/pfizer-lifts-2026-sales-forecast-to-up-to-625-billion

### 2026-07-29: Bristol Myers Squibb raises 2026 revenue and profit outlook

Bristol Myers Squibb posted Q2 revenue of $12.97 bn, raised 2026 revenue guidance to $49‑$50 bn, and lifted Eliquis sales forecast to 20‑25 % growth after a 22 % sales jump.

20 sources. https://clstr.news/cluster/french-pharma-companies-euroapi-and-biomrieux-lower-financial-outlooks-for-20262028

---
Cite as: US pharma companies raise 2026 outlooks. CLSTR, https://clstr.news/situations/us-pharma-companies-raise-2026-outlooks